Sevoflurane Mersifarma Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Sevoflurane

Indications/Uses

Induction & maintenance of general anesth.

Dosage/Direction for Use

Individualized dosage. Maintenance of surgical anesth 0.5-3% w/ or w/o concomitant nitrous oxide.

Contraindications

Hypersensitivity to sevoflurane or other halogenated agents. Suspected susceptibility to malignant hyperthermia.

Special Precautions

Hypersensitivity to volatile halogenated anesth. Use for long procedures at low flow rate. Patients at risk for seizures. Renal insufficiency. Pregnancy & lactation. Childn 1-18 yr. Elderly.

Adverse Reactions

Cardioresp depression, hypotension, malignant hyperthermia. Agitation, laryngospasm, acute renal failure, increased cough & salivation; shivering, nausea, vomiting during post-op period.

View ADR Monitoring Form

Drug Interactions

Benzodiazepines & opioids. Decreased anesth requirement w/ nitrous oxide. Increase intensity & duration of neuromuscular blockade induced by non-depolarizing muscle relaxants.

MIMS Class

Anaesthetics - Local & General

ATC Classification

N01AB08 - sevoflurane ; Belongs to the class of halogenated hydrocarbons. Used as general anesthetics.

Regulatory Classification

Presentation/Packing

Form

Sevoflurane Mersifarma liqd for inhalation 250 mL

Packing/Price

1's (Rp994,892/boks)

Sevoflurane Mersifarma

sevoflurane

Manufacturer:

Mersifarma TM